Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Lower Risk of Hypoglycemia Like semaglutide, tirzepatide carries a lower risk of causing hypoglycemia, thanks to its glucose-dependent action.
The dual GLP-1 and GIP receptor activation produces metabolic changes that show up relatively quickly in laboratory measurements and research endpoints
On the liver itself, they reduce the gluconeogenesis [process of creating glucose in the liver and kidneys from non-carbo-hydrate sources, which help maintain blood sugar levels when dietary intake is low], reducing hepatic fat formation and metabolic dysfunction associated with fatty liver disease
Selenium supplementation does not affect testicular selenium status or semen quality in north American men
10.1074/jbc.m305838200 37 SongS.KimS
Clinical trials have shown average weight loss of up to 22.5 percent of body weight at the highest dose over 72 weeks, making it one of the most effective pharmacological weight loss treatments available
